Afya (NASDAQ:AFYA) Price Target Cut to $19.00 by Analysts at Morgan Stanley

Afya (NASDAQ:AFYAFree Report) had its price target reduced by Morgan Stanley from $21.00 to $19.00 in a research report report published on Friday morning, Benzinga reports. They currently have an equal weight rating on the stock.

Afya Price Performance

Afya stock opened at $16.64 on Friday. Afya has a 12 month low of $13.09 and a 12 month high of $22.48. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 0.42. The business’s 50 day simple moving average is $17.37 and its 200 day simple moving average is $19.35. The company has a market cap of $1.56 billion, a price-to-earnings ratio of 15.55, a PEG ratio of 0.43 and a beta of 0.96.

Afya (NASDAQ:AFYAGet Free Report) last announced its quarterly earnings results on Thursday, May 9th. The company reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.07. Afya had a net margin of 16.20% and a return on equity of 17.51%. The company had revenue of $162.45 million for the quarter, compared to analysts’ expectations of $152.98 million. Sell-side analysts forecast that Afya will post 1.63 EPS for the current year.

Hedge Funds Weigh In On Afya

Hedge funds have recently bought and sold shares of the company. Itau Unibanco Holding S.A. boosted its stake in Afya by 1,004.5% during the third quarter. Itau Unibanco Holding S.A. now owns 144,264 shares of the company’s stock valued at $2,279,000 after buying an additional 131,202 shares during the period. Raymond James & Associates lifted its position in Afya by 134.4% in the 4th quarter. Raymond James & Associates now owns 27,695 shares of the company’s stock worth $607,000 after buying an additional 15,878 shares during the last quarter. Raymond James Financial Services Advisors Inc. boosted its stake in shares of Afya by 123.7% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 25,925 shares of the company’s stock valued at $569,000 after purchasing an additional 14,337 shares in the last quarter. HBK Sorce Advisory LLC boosted its position in Afya by 10.0% during the fourth quarter. HBK Sorce Advisory LLC now owns 11,044 shares of the company’s stock valued at $242,000 after buying an additional 1,000 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in Afya during the 4th quarter valued at about $245,000. Hedge funds and other institutional investors own 88.02% of the company’s stock.

About Afya

(Get Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

See Also

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.